Human Gene TherapyVol. 32, No. 7-8 EditorialWomen Lead Gene Therapy Science in 2021Jennifer E. Adair, Karla Shepard Rubinger, and Terence R. FlotteJennifer E. Adair*Correspondence: Dr. Jennifer E. Adair, Associate Editor, Human Gene Therapy, Worcester, MA, USA. E-mail: E-mail Address: jadair@fredhutch.orgEditors, Human Gene Therapy, Worcester, MA, USA.Search for more papers by this author, Karla Shepard RubingerExecutive Director, Rosalind Franklin Society, New Rochelle, NY, USA.Search for more papers by this author, and Terence R. FlotteEditors, Human Gene Therapy, Worcester, MA, USA.Search for more papers by this authorPublished Online:19 Apr 2021https://doi.org/10.1089/hum.2021.29155.jeaAboutSectionsView articleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article"Women Lead Gene Therapy Science in 2021." Human Gene Therapy, 32(7-8), pp. 317–318FiguresReferencesRelatedDetails Volume 32Issue 7-8Apr 2021 InformationCopyright 2021, by Mary Ann Liebert, Inc., publishersTo cite this article:Jennifer E. Adair, Karla Shepard Rubinger, and Terence R. Flotte.Human Gene Therapy.Apr 2021.317-318.http://doi.org/10.1089/hum.2021.29155.jeaPublished in Volume: 32 Issue 7-8: April 19, 2021PDF download